Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients

Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients

Abstract Metabolic brain biomarkers have been incorporated in various diagnostic guidelines of neurodegenerative diseases, recently. To improve their diagnostic accuracy a biologically and clinically homogeneous sample is needed for their identification. Alzheimer’s disease-related pattern (ADRP) ha...

Full description

Bibliographic Details
Main Authors:	Matej Perovnik, Petra Tomše, Jan Jamšek, Andreja Emeršič, Chris Tang, David Eidelberg, Maja Trošt
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-07-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-15667-9

Similar Items

Automated differential diagnosis of dementia syndromes using FDG PET and machine learning
by: Matej Perovnik, et al.
Published: (2022-11-01)

Effect of the identification group size and image resolution on the diagnostic performance of metabolic Alzheimer’s disease-related pattern
by: Eva Štokelj, et al.
Published: (2023-05-01)

Genetic Polymorphisms in Oxidative Stress and Inflammatory Pathways as Potential Biomarkers in Alzheimer’s Disease and Dementia
by: David Vogrinc, et al.
Published: (2023-01-01)

Blood Biomarkers for Alzheimer’s Dementia Diagnosis
by: Chang-Eun Park
Published: (2022-12-01)

Validation of the brain health index in the European Prevention of Alzheimer's Dementia cohort
by: Jodi K. Watt, et al.
Published: (2024-01-01)

Biomarkers in alzheimer’s dementia: health system and ageism
by: Francisco Javier Balea Fernández, et al.
Published: (2020-06-01)

Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
by: Winchester, LM, et al.
Published: (2023)

Metabolic Brain Changes Can Predict the Underlying Pathology in Neurodegenerative Brain Disorders: A Case Report of Sporadic Creutzfeldt–Jakob Disease with Concomitant Parkinson’s Disease
by: Tomaž Rus, et al.
Published: (2023-08-01)

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease
by: Olivier Bousiges, et al.
Published: (2022-06-01)

Spanish translation, retranslation, and content validation of the Quality of Life in Alzheimer’s Disease scale in patients with Alzheimer’s dementia
by: Aldo Vera-Calzaretta, et al.
Published: (2023-07-01)

Clinico‐pathological comparison of patients with autopsy‐confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology
by: Atri Chatterjee, et al.
Published: (2021-01-01)

Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
by: Giulia Giacomucci, et al.
Published: (2021-01-01)

Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease
by: Dan Pan, et al.
Published: (2023-02-01)

New Treatments for Alzheimer’s Dementia
by: Liliana Moreno, et al.
Published: (2023-03-01)

TETRAHYDROBIOPTERIN METABOLISM IN SENILE DEMENTIA OF ALZHEIMER TYPE
by: Jones, S, et al.
Published: (1987)

Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
by: Morar, C, et al.
Published: (1983)

Dementia: Not Only Alzheimer’s disease, an Eye on Frontotemporal Dementia
by: Daniela Galimberti, et al.
Published: (2013-08-01)

Comparison of potential plasma biomarkers in Alzheimer’s disease and neurodegenerative dementias in Pakistani population
by: Tehniat Faraz Ahmed, et al.
Published: (2023-09-01)

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
by: Pai-Yi Chiu, et al.
Published: (2022-10-01)

PET-validated EEG-machine learning algorithm predicts brain amyloid pathology in pre-dementia Alzheimer’s disease
by: Nam Heon Kim, et al.
Published: (2023-06-01)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
by: Jagan A. Pillai, et al.
Published: (2023-03-01)

The temporal lobe in dementia of Alzheimer's type.
by: Wilcock, G
Published: (1983)

Donepezil for dementia due to Alzheimer's disease
by: Birks, J, et al.
Published: (2018)

Presenilins in Alzheimer’s disease and frontotemporal dementia
by: Shen Jie
Published: (2012-02-01)

Shape-Attributes of Brain Structures as Biomarkers for Alzheimer’s Disease
by: Glozman, Tanya, et al.
Published: (2017)

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
by: Alfonso Delgado-Álvarez, et al.
Published: (2023-01-01)

Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
by: Jonathan Kopel, et al.
Published: (2023-03-01)

Cure of Alzheimer’s Dementia Requires Addressing All of the Affected Brain Cell Types
by: Jeffrey Fessel
Published: (2023-03-01)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
by: Lourdes Álvarez-Sánchez, et al.
Published: (2023-01-01)

COMPARISON OF POTENTIAL PLASMA BIOMARKERS IN ALZHEIMER’S DISEASE AND OTHER NEURODEGENERATIVE DEMENTIAS IN PAKISTANI POPULATION
by: Tehniat Ahmed, et al.
Published: (2023-10-01)

Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients
by: Florin V. Chirila, et al.
Published: (2022-11-01)

Blood‐based biomarkers for Alzheimer's disease and related dementias: Keys to success and things to consider
by: Henrik Zetterberg, et al.
Published: (2019-12-01)

Dementia Pugilistica with clinical features of Alzheimer's disease Dementia pugilistica com características clínicas de doença de Alzheimer
by: Renata Areza-Fegyveres, et al.
Published: (2007-09-01)

Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
by: Westwood, S, et al.
Published: (2020)

Biomarkers in Alzheimer’s disease
by: Janeiro Manuel H., et al.
Published: (2020-11-01)

PUBLIC AWARENESS OF AND ENGAGEMENT IN ACTIVE CARE FOR BRAIN HEALTH IN SLOVENIA
by: Maja Bresjanac, et al.
Published: (2023-10-01)

The Frontal Assessment Battery (FAB) effectively discriminates between MCI and dementia within the clinical spectrum of neurochemically confirmed Alzheimer’s disease
by: Edoardo Nicolò Aiello, et al.
Published: (2022-11-01)

The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach.
by: Hogervorst, E, et al.
Published: (2003)

Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
by: Nazib M Seidu, et al.
Published: (2024-01-01)

Effects of Physical Activity on Brain Energy Biomarkers in Alzheimer’s Diseases
by: Khadijeh Ebrahimi, et al.
Published: (2020-06-01)